Skip to main content

The AHRQ National Quality Measures Clearinghouse (NQMC, qualitymeasures.ahrq.gov) Web site will not be available after July 16, 2018 because federal funding
through AHRQ will no longer be available to support the NQMC as of that date. For additional information, read our full announcement.
  • Measure Summary
  • NQMC:010243
  • Mar 2015

Diagnostic imaging: percentage of screenings for lung cancer with abnormal interpretation (Lung-RADS 3 or 4) that result in a tissue diagnosis of cancer within 12 months.

American College of Radiology (ACR). National Radiology Data Registry: qualified clinical data registry. Non-PQRS measures. Reston (VA): American College of Radiology (ACR); 2015 Mar. 49 p.

View the original measure documentation External Web Site Policy

This is the current release of the measure.

The measure developer reaffirmed the currency of this measure in March 2017.

Primary Measure Domain

Clinical Quality Measures: Process

Secondary Measure Domain

Does not apply to this measure

Description

This measure is used to assess the percentage of screenings for lung cancer with abnormal interpretation (Lung Imaging Reporting and Data System [Lung-RADS] category 3 or 4) that result in a tissue diagnosis of cancer within 12 months.

Rationale

Lung cancer is the leading cause of cancer for both men and women, with more than 156,000 patients dying from lung cancer each year in the United States, a figure that is greater than the mortality rates of breast, prostate, and colon cancer combined. Furthermore, lung cancer is the leading cause of cancer death in every racial and ethnic subgroup, and is the leading cancer killer of women, taking more lives than breast and every gynecological cancer combined.

Lung cancer screening (LCS) with low dose computed tomography (LDCT) is the only procedure proven to reduce lung cancer mortality in individuals at high-risk for lung cancer, and does so cost effectively. A clinical practice registry is essential to ensure that screening is performed in general clinical practice at a high level of quality that can replicate the results found in research without undue risk. The measures included in the registry monitor cancer detection rate and positive predictive value to guide physicians towards low false positive rates and screening of the appropriate population, and radiation dose indices to ensure that radiation exposure to this screening population is no higher than necessary. Measures related to imaging interpretation are based on Lung Imaging Reporting and Data System (Lung-RADS), a set of structured assessment categories for reporting on lung cancer screening.

Positive predictive value 2 (PPV2) is a useful approximation of the other type of false-positive outcome (biopsy with benign diagnosis). A high true positive rate is indicative of patient receiving most clinically appropriate care.

Evidence for Rationale

American Association of Physicists in Medicine (AAPM). Lung cancer screening CT protocols, version 3.0. Alexandria (VA): American Association of Physicists in Medicine (AAPM); 2015 Jul 3. 15 p.

American College of Radiology (ACR). National Radiology Data Registry: qualified clinical data registry. Non-PQRS measures. Reston (VA): American College of Radiology (ACR); 2015 Mar. 49 p.

Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C, National Lung Screening Trial Research Team. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014 Nov 6;371(19):1793-802. PubMed External Web Site Policy

McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015 Mar;12(3):273-6. PubMed External Web Site Policy

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. PubMed External Web Site Policy

Pinsky PF, Gierada DS, Hocking W, Patz EF, Kramer BS. National lung screening trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med. 2014 Nov 4;161(9):627-33. PubMed External Web Site Policy

Primary Health Components

Lung cancer screening; computed tomography (CT); Lung Imaging Reporting and Data System (Lung-RADS); abnormal interpretation; tissue diagnosis

Denominator Description

Number of screening exams with a Lung Imaging Reporting and Data System (Lung-RADS) assessment category of 3 or 4

Numerator Description

Number of screening exams with a Lung Imaging Reporting and Data System (Lung-RADS) assessment category of 3 or 4 that had a tissue diagnosis of cancer within 12 months (see the related "Numerator Inclusions/Exclusions" field)

Type of Evidence Supporting the Criterion of Quality for the Measure

  • A formal consensus procedure, involving experts in relevant clinical, methodological, public health and organizational sciences
  • One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal

Additional Information Supporting Need for the Measure

Unspecified

Extent of Measure Testing

The measures in this set are being made available without any prior formal testing. However, these measures are included in the Centers for Medicare and Medicaid Services (CMS) approved American College of Radiology (ACR) National Radiology Data Registry, a CMS Physician Quality Reporting System (PQRS) Qualified Clinical Data Registry since 2014.

The ACR recognizes the importance of thorough testing all of its measures and encourages ongoing robust testing of the ACR National Radiology Data Registry measurement set for feasibility and reliability by organizations or individuals positioned to do so. The ACR will welcome the opportunity to promote such testing of these measures and to ensure that any results available from testing are used to refine the measures on an ongoing basis. Since these measures are in use for quality improvement and reporting, we can support data analysis of registry data to perform the testing, such as evaluation of gaps for validity testing, and signal-to-noise estimation for reliability testing.

Evidence for Extent of Measure Testing

Blakey A. (Administrator, Quality Management Programs, American College of Radiology, Reston, VA). Personal communication. 2016 Mar 7.  1 p.

State of Use

Current routine use

Current Use

Internal quality improvement

Pay-for-reporting

Professional certification

Public reporting

Measurement Setting

Ambulatory/Office-based Care

Ambulatory Procedure/Imaging Center

Hospital Inpatient

Hospital Outpatient

Professionals Involved in Delivery of Health Services

Physicians

Least Aggregated Level of Services Delivery Addressed

Individual Clinicians or Public Health Professionals

Statement of Acceptable Minimum Sample Size

Unspecified

Target Population Age

Unspecified

Target Population Gender

Either male or female

National Quality Strategy Aim

Better Care

National Quality Strategy Priority

Health and Well-being of Communities
Prevention and Treatment of Leading Causes of Mortality

IOM Care Need

Living with Illness

Staying Healthy

IOM Domain

Effectiveness

Case Finding Period

Unspecified

Denominator Sampling Frame

Patients associated with provider

Denominator (Index) Event or Characteristic

Diagnostic Evaluation

Denominator Time Window

Does not apply to this measure

Denominator Inclusions/Exclusions

Inclusions
Number of screening exams with a Lung Imaging Reporting and Data System (Lung-RADS) assessment category of 3 or 4

Exclusions
None

Exclusions/Exceptions

None

Numerator Inclusions/Exclusions

Inclusions
Number of screening exams with a Lung Imaging Reporting and Data System (Lung-RADS) assessment category of 3 or 4 that had a tissue diagnosis* of cancer within 12 months

*Tissue diagnosis field = 2, 4 or 5

Exclusions
Unspecified

Numerator Search Strategy

Fixed time period or point in time

Data Source

Registry data

Type of Health State

Does not apply to this measure

Instruments Used and/or Associated with the Measure

Lung Imaging Reporting and Data System (Lung-RADS)

Measure Specifies Disaggregation

Does not apply to this measure

Scoring

Rate/Proportion

Interpretation of Score

Desired value is a higher score

Allowance for Patient or Population Factors

Unspecified

Standard of Comparison

External comparison at a point in, or interval of, time

Internal time comparison

Original Title

Lung cancer screening positive predictive value (PPV).

Measure Collection Name

National Radiology Data Registry Measurement Set

Submitter

American College of Radiology - Medical Specialty Society

Developer

American College of Radiology - Medical Specialty Society

Funding Source(s)

None

Composition of the Group that Developed the Measure

The American College of Radiology (ACR) National Radiology Data Registry (NRDR) helps facilities benchmark outcomes and process-of-care measures and to develop quality improvement programs. The composition of the workgroup is has representation from each of our six data registries:

  1. CT Colonography Registry Committee (CTC)
  2. Dose Index Registry Committee (DIR)
  3. General Radiology Improvement Database Committee (GRID)
  4. National Mammography Database Committee (NMD)
  5. Lung Cancer Screening Registry Committee (LCSR)
  6. IR & INR Registries (Interventional Radiology)

Committee Members

  • Morin Richard, PhD, FACR, Chair of NRDR
  • Kalpana Kanal, PhD, Chair of DIR
  • Zuley Margarita, MD, Chair of NMD
  • Abe Dachman, MD, Chair of CTC Committee
  • Frank Rybicki, MD, Chair of Metrics Committee
  • Siegel Eliot, MD, RSNA Liaison
  • Chad Calendine, MD, Co-Chair of GRID
  • Geoffrey Wiot, Co-Chair of GRID
  • Jeremy Durack, Chair of IR Registry Committee
  • Ella Kazerooni, Co-Chair of Lung-Cancer Screening Committee
  • Deni Aberle, Co-Chair of Lung-Cancer Screening Committee

Committee Staff

  • Judy Burleson, MHSA, American College of Radiology
  • Mythreyi Bhargavan Chatfield, PhD, American College of Radiology

Financial Disclosures/Other Potential Conflicts of Interest

Unspecified

Adaptation

This measure was not adapted from another source.

Date of Most Current Version in NQMC

2015 Mar

Measure Maintenance

This measure is reviewed annually

Date of Next Anticipated Revision

2017 Mar

Measure Status

This is the current release of the measure.

The measure developer reaffirmed the currency of this measure in March 2017.

Source(s)

American College of Radiology (ACR). National Radiology Data Registry: qualified clinical data registry. Non-PQRS measures. Reston (VA): American College of Radiology (ACR); 2015 Mar. 49 p.

Measure Availability

Source available from the American College of Radiology (ACR) Web site External Web Site Policy.

For more information, contact ACR at 1891 Preston White Drive, Reston, VA 20191; Phone: 703-648-8900; E-mail: nrdr@acr.org; Web site: www.acr.org External Web Site Policy.

NQMC Status

This NQMC measure summary was completed by ECRI Institute on December 11, 2015. The information was verified by the measure developer on March 7, 2016.

The information was reaffirmed by the measure developer on March 3, 3017.

Copyright Statement

This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.

©2014 American College of Radiology. All Rights Reserved.

NQMC Disclaimer

The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.

All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.

Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the NQMC Inclusion Criteria.

NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding measure content are directed to contact the measure developer.

About NQMC Measure Summaries

NQMC provides structured summaries containing information about measures and their development.

Measure Summary FAQs


Measure Summaries

New This Week

View more and sign up for our Newsletter

Get Adobe Reader